Bespoke Extracts, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OTC.Pink
Bespoke Extracts, Inc. President and Director Garth Tyler Hunter was granted 200,000 restricted common shares, vesting in one year.
OTC.Pink
Bespoke Extracts CEO Michael Feinsod increased his beneficial ownership by purchasing 3,500 shares of common stock in two separate transactions.
OTC.Pink
Bespoke Extracts, Inc. CEO Michael Feinsod purchased 2,500 shares of common stock at $0.19 per share, increasing his beneficial ownership to over 2.5 million shares.
OTC.Pink
Bespoke Extracts' CEO and 10% owner, Michael Feinsod, purchased 2,500 shares of common stock at $0.20 per share, signaling confidence.
OTC.Pink
Bespoke Extracts, Inc. CEO and Director Michael Feinsod has acquired 8,000 shares of common stock, increasing his beneficial ownership to over 2.5 million shares.
OTC.Pink
CEO Michael Feinsod reports purchasing additional shares of Bespoke Extracts, Inc. on May 9th and May 12th, 2025.
OTC.Pink
Bespoke Extracts CEO Michael Feinsod has increased his direct holdings of the company's common stock through open market purchases.
OTC.Pink
CEO Michael Feinsod reports purchasing additional shares of Bespoke Extracts, Inc. on January 22nd and 23rd, 2025.
OTC.Pink
CEO Michael Feinsod reports purchasing additional shares of Bespoke Extracts, Inc. on January 2nd and 3rd, 2025.
OTC.Pink
Bespoke Extracts CEO Michael Feinsod has increased his holdings in the company through recent stock purchases.
OTC.Pink
CEO Michael Feinsod reports purchasing additional shares of Bespoke Extracts, Inc. common stock.
OTC.Pink
CEO Michael Feinsod reports purchasing additional shares of Bespoke Extracts, Inc. on August 27th and 28th, 2024.
OTC.Pink
Tyler Hunter Garth, President of Bespoke Extracts, Inc., reports acquiring 300,000 shares of common stock and disposing of 800,000 shares on August 15, 2024.
OTC.Pink
Michael Feinsod, CEO of Bespoke Extracts, Inc., reports the acquisition of 300,000 shares of restricted stock on August 15, 2024.
OTC.Pink
CEO Michael Feinsod reports purchasing additional shares of Bespoke Extracts, Inc. on August 1st and 2nd, 2024.
OTC.Pink
CEO Michael Feinsod reports purchasing 3,000 shares of Bespoke Extracts, Inc. at $0.07 per share on July 22, 2024, while also disclosing the disposal of 2,148,112 shares.
OTC.Pink
CEO Michael Feinsod reports purchasing 3,000 shares of Bespoke Extracts, Inc. at $0.07 per share, while also disclosing indirect ownership through Infinity Management, LLC.
OTC.Pink
CEO Michael Feinsod reports purchasing 4,000 shares of Bespoke Extracts, Inc. at $0.13 per share on June 17, 2024.
OTC.Pink
CEO Michael Feinsod reports purchasing additional shares of Bespoke Extracts, Inc. common stock.
OTC.Pink
CEO Michael Feinsod reports purchasing 3,000 shares of Bespoke Extracts, Inc. at $0.15 per share.
OTC.Pink
CEO Michael Feinsod reports purchasing 3,000 shares of Bespoke Extracts, Inc. at $0.11 per share.
OTC.Pink
Bespoke Extracts CEO Michael Feinsod reports purchasing 5,000 shares of company stock at $0.11 per share on April 24, 2024.
OTC.Pink
Form 4: Bespoke Extracts CEO Michael Feinsod Acquires Shares and Disposes of Shares in Recent Transaction
CEO Michael Feinsod reports purchasing 5,000 shares of Bespoke Extracts, Inc. at $0.15 per share and disposing of 2,125,112 shares.
OTC.Pink
Tyler Hunter Garth, President of Bespoke Extracts, Inc., reports the acquisition of 30,000 stock options with an exercise price of $0.22.
OTC.Pink
Michael Feinsod, CEO of Bespoke Extracts, Inc., reports the acquisition of 15,000 options in the company.